North America is the largest market for naloxone hydrochloride, driven by the ongoing opioid overdose crisis, particularly the spread of illicit fentanyl in the US and Canada. Demand has been boosted by the FDA's 2023 approval of over-the-counter naloxone nasal spray, along with federal and state funding, standing orders and community distribution programs that put the drug in the hands of...